Shanghai MicroPort Endovascular MedTech(Group)Co.,Ltd. (688016.SH): The second phase has accumulated a repurchase of 91.5606 million yuan of company shares.

According to Gelonghui on April 2, Shanghai MicroPort Endovascular MedTech(Group)Co.,Ltd. (688016.SH) announced that as of March 31, 2025, the company has repurchased a total of 864,989 shares through the centralized bidding trading system of the Shanghai Stock Exchange (Phase II), with the highest transaction price at 119.82 yuan/share, the lowest price at 93.10 yuan/share, and the total amount paid was 91.5606 million yuan (excluding stamp duty, trading commission, and other transaction fees).

Gelonghui FinanceApr 2 04:31 ET

Earnings Miss: Shanghai MicroPort Endovascular MedTech Co., Ltd. Missed EPS By 25% And Analysts Are Revising Their Forecasts

Simply Wall StApr 1 18:31 ET

Cardiac Care: 2024 Annual Report Summary

SZSIMar 28 12:00 ET · Announcements

Cardiac Care: 2024 Annual Report

SZSIMar 28 12:00 ET · Announcements

Shanghai MicroPort Endovascular MedTech(Group)Co.,Ltd. (688016.SH) released its 2024 annual performance, with a net income of 0.502 billion yuan, a year-on-year increase of 1.96%.

Shanghai MicroPort Endovascular MedTech(Group)Co.,Ltd. (688016.SH) released its annual report for 2024, stating that the revenue for 2024 is 12...

Zhitong FinanceMar 28 11:50 ET

Earnings Growth of 3.7% Over 3 Years Hasn't Been Enough to Translate Into Positive Returns for Shanghai MicroPort Endovascular MedTech (SHSE:688016) Shareholders

Simply Wall StMar 24 20:46 ET